Mechanism of Action of Colchicine in the Treatment of Gout
Top Cited Papers
Open Access
- 1 October 2014
- journal article
- review article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 36 (10), 1465-1479
- https://doi.org/10.1016/j.clinthera.2014.07.017
Abstract
No abstract availableKeywords
This publication has 126 references indexed in Scilit:
- Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritisArthritis & Rheumatism, 2011
- Microtubule-mediated NF-κB activation in the TNF-α signaling pathwayExperimental Cell Research, 2009
- Receptor-Independent, Direct Membrane Binding Leads to Cell-Surface Lipid Sorting and Syk Kinase Activation in Dendritic CellsImmunity, 2008
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and SilicaScience, 2008
- Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low‐dose colchicineBritish Journal of Pharmacology, 2008
- Modulation of TGF-β signaling by proinflammatory cytokines in articular chondrocytesOsteoarthritis and Cartilage, 2007
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.JCI Insight, 1998
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992